---
title: "Burford Capital Review"
url: https://altstreet.investments/platforms/reviews/burford-capital
kind: platform-review
updated: 2026-09-15
description: "Burford Capital (NYSE: BUR) funds commercial lawsuits, not consumer loans. Review: 83% ROIC and 26% IRR on concluded matters, the YPF reversal."
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Burford Capital Review

NYSE- and LSE-listed equity proxy for commercial litigation finance — $7.5B portfolio, 83% cumulative ROIC, 26% IRR on concluded matters — but the March 2026 YPF Second Circuit reversal and an unremediated internal control weakness are the two facts every investor needs to sit with before buying.

AltStreet score: 71.2 (A-), scored August 14, 2026. Method: https://altstreet.investments/platforms

| Field | Value |
| --- | --- |
| Platform | Burford Capital |
| What it is | Litigation Finance Public Company |
| Asset class | Legal Claims — Commercial Litigation & Arbitration |
| Website | burfordcapital.com |
| Review first published | January 13, 2026 |
| Last updated | September 15, 2026 |
| AltStreet relationship | None: no affiliate, sponsorship or partnership |

## The short version

Burford is the most credible public-equity proxy for commercial litigation finance. The 15-year track record — 83% cumulative ROIC and 26% IRR on concluded matters across roughly $3.8B in lifetime realizations — is real, audited (KPMG as of July 2024), and hard for any private platform to match on scale. The structural risks are also real: fair value accounting creates quarterly earnings that bear little resemblance to cash generation, YPF-related assets represent 46% of the portfolio after the March 2026 Second Circuit reversal introduced a material headwind, and an internal control weakness over fair value measurement was unremediated as of December 31, 2024. BUR is a long-term equity position for investors who understand what they are buying — a leveraged, long-duration, opaque underwriting business that happens to trade on a stock exchange.

- **83% / 26%** Cumulative ROIC / IRR on concluded capital provision-direct matters since inception per company disclosure. FY2024 concluded matters: ROIC 87%, IRR 26%. FY2025: ROIC 83%, IRR 26%. Strong and consistent but concentrated in specific vintages and outsized wins.
- **$7.5B** Total group-wide portfolio as of FY2025. Portfolio base $2.85B. $872M new definitive commitments in FY2025. $710.5M realizations (down from $907M in FY2024). Liquidity $621M.
- **46%** YPF-related assets as percentage of capital provision assets as of December 31, 2025 — up from 42% in FY2024. March 27, 2026 Second Circuit reversal materially impacted the fair value of these assets in Q1 2026, not reflected in FY2025 financials.
- **Unremediated** Material weakness in internal controls over fair value measurement of capital provision assets — first disclosed in FY2023 20-F, still unremediated as of December 31, 2024 per FY2024 10-K. Auditor changed from EY to KPMG on July 1, 2024.
- **$0.125** Annual dividend per share (semi-annual cadence, $0.0625 per payment) — consistent across FY2022, FY2023, FY2024, FY2025. Total annual dividends approximately $27M. Not a yield vehicle — treat as total-return equity.

Data note: AltStreet tracks FY2022–FY2025 annual plus Q1 2026 quarterly performance history for Burford Capital from primary 10-K and 10-Q filings via ingestPublicFilings.ts. Two EDGAR exit records: Burford Alternative Income Fund II LP ($303M, 7 institutional investors, 506(b), May 2022) and Burford Advantage Master Fund LP ($293M, 6 qualified purchasers, 506(b), first sale December 2021, per April 2022 Form D/A). Six pre-open Burford fund entities confirmed at $0 Reg D capital — institutional capital raised outside Reg D.


## Key figures

| Figure | What it is | Context |
| --- | --- | --- |
| 83% / 26% | Cumulative ROIC / IRR on concluded matters — FY2025 | 15-year track record, KPMG-audited. FY2024: 87% ROIC, 26% IRR. Consistent but concentrated in specific vintages and outsized wins. |
| 46% | YPF-related assets as % of capital provision portfolio — December 31, 2025 | Second Circuit reversed the YPF judgment March 27, 2026; Q1 2026 recorded a $1.63B net loss as the reversal hit the books. Up from 42% in FY2024. |
| Unremediated | Material weakness in ICFR over fair value measurement of capital provision assets | First disclosed FY2023. Still unremediated as of December 31, 2024 per KPMG attestation. No misstatements per management. |
| $710.5M | FY2025 realizations — the correct earnings metric, not GAAP net income | Cash received from concluded cases: FY2025 $710.5M, FY2024 $991.3M, FY2023 $559.4M. GAAP net income ($62.6M in FY2025) reflects fair value movements, not cash. |


## Verdict

Burford is a legitimate institutional-quality business with a 15-year track record that no retail-accessible litigation finance platform can match. The public listing provides daily liquidity, SEC-audited financials, and diversification across 100+ active matters. The risks are specific and material: YPF concentration at 46% of portfolio creates binary event risk, the unremediated ICFR weakness raises questions about fair value precision, and the 7.5% coupon on recent debt issuances reflects real leverage risk. Sophisticated long-term investors seeking liquid alternative asset exposure will find BUR the most credible entry point in the category. Short-term traders, income seekers, and investors who cannot tolerate quarterly fair-value earnings volatility should look elsewhere.

**Best for**

- Sophisticated long-term equity investors (5–7 year horizon) seeking alternative asset exposure through a liquid public security without private fund lockups
- Alternatives allocators who want diversified commercial litigation finance exposure across 100+ matters managed by a 45+ lawyer institutional team
- Investors comfortable with fair value accounting mechanics and willing to evaluate BUR on cumulative cash realizations rather than quarterly GAAP earnings
- Taxable account holders seeking qualified dividend treatment and long-term capital gains on stock appreciation

**Look elsewhere if**

- You need quarterly income predictability — fair value accounting creates earnings volatility entirely unrelated to cash generation
- You want case-level transparency or the ability to select specific litigation investments — public shareholders have no visibility into individual underwriting decisions
- You are evaluating BUR as a lower-risk alternative to private litigation finance — the YPF concentration and ICFR weakness mean this is not a low-risk position
- You have a horizon shorter than 3–5 years — case realization timing is inherently unpredictable and stock price may not reflect underlying value in the short term

**Strengths**

- 15-year track record with 83% cumulative ROIC and 26% IRR on concluded matters — the most credible public performance history in commercial litigation finance
- NYSE/LSE listing provides daily liquidity, SEC-audited financials, and regulated disclosure — structural advantages over private litigation finance alternatives
- 93% recovery rate on concluded matters by deployed capital demonstrates consistent underwriting quality across 15+ years and multiple market cycles
- Scale ($7.5B portfolio, 45+ in-house lawyers, 160+ employees) creates origination, underwriting, and enforcement capabilities no retail platform can replicate

**Limitations**

- YPF-related assets at 46% of capital provision portfolio create dangerous single-case concentration — March 2026 Second Circuit reversal is a material Q1 2026 headwind
- Unremediated material weakness in internal controls over fair value measurement of capital provision assets (disclosed FY2023, unresolved FY2024) creates independent verification concerns
- Fair value accounting produces quarterly earnings that bear no predictable relationship to cash generation — sophisticated understanding required to avoid misinterpreting results
- 7.5% coupon on July 2025 senior notes reflects real leverage and refinancing risk; net debt at 22% of tangible assets creates meaningful sensitivity to capital markets conditions


## Who it fits

| Investor | Fit | Why |
| --- | --- | --- |
| Sophisticated Long-Term Equity Investors | well-suited |  |
| Alternatives Allocators — Diversification Mandate | well-suited |  |
| Income Investors | poor-fit |  |
| Short-Term Traders | poor-fit |  |
| Risk-Averse Investors | poor-fit |  |


## Questions

**What is Burford Capital and how does it make money?**

Burford provides capital to fund commercial lawsuits and arbitrations in exchange for a percentage of recoveries. Company finances legal fees, expert costs, and expenses for corporations and law firms. Makes money when cases win or settle favorably, receiving agreed share of proceeds. Loses investment if case unsuccessful. Investors access through public stock (NYSE/LSE: BUR) — not direct case participation.

**What are Burford's historical returns?**

83% cumulative ROIC and 26% IRR on concluded capital provision-direct matters since inception per FY2025 10-K disclosure. Approximately $3.8B in lifetime realizations. FY2024 concluded matters: 87% ROIC. These figures include outlier mega-cases (YPF, Akhmedov) and reflect a 15-year period including early first-mover advantage. Future returns may be lower or lumpier.

**What happened with YPF and why does it matter?**

YPF-related assets represented 46% of Burford's capital provision portfolio as of December 31, 2025. The district court ruled in Burford's favor in 2023, generating approximately $1.3B in unrealized fair value gains that elevated FY2023 net income. On March 27, 2026, the Second Circuit reversed that judgment. Burford's Q1 2026 10-Q quantified the impact: negative $2,498.8M of capital provision income, a $1,632.1M net loss, and tangible book value of $3.17 per share.

**What is the material weakness Burford disclosed?**

Burford disclosed an internal control weakness over the fair value measurement of capital provision assets — first in its FY2023 Form 20-F, still unremediated as of December 31, 2024 per the FY2024 10-K. The weakness relates to the precision of management's review controls for the assumptions underlying litigation asset valuations. Management states no misstatements resulted. KPMG confirmed the weakness in its attestation report.

**Why did Burford change auditors from EY to KPMG?**

EY was dismissed effective July 1, 2024 — immediately after the Q2 2024 financial statements. KPMG was appointed the same day for Q3 2024 through FY2024. Both firms' consents appear in the FY2024 10-K. Burford reported the change via Form 6-K on July 9, 2024. The transition coincided with an unremediated material weakness in internal controls — the timing warrants investor awareness though no causal connection has been established.

**How does Burford's stock work as a litigation finance investment?**

Buying BUR gives you equity exposure to Burford's entire litigation finance portfolio — not direct ownership of individual cases. Returns come from stock appreciation and dividends ($0.125/share annually). Fair value accounting produces quarterly earnings that often bear no relationship to cash generation. The correct metric to follow is realizations: cash received from concluded cases ($710.5M in FY2025, $991.3M in FY2024).

**What are the main risks of investing in Burford?**

Four specific near-term risks: (1) YPF concentration at 46% after the March 2026 Second Circuit reversal — most material near-term risk; (2) unremediated ICFR material weakness over core asset valuations; (3) rising debt load at increasing cost (7.5% coupon on July 2025 notes); (4) fair value accounting volatility that creates misleading quarterly earnings. Long-term risks include competition, regulatory change, and enforcement challenges on sovereign cases.

**How does Burford compare to private litigation finance platforms like LexShares?**

LexShares raised $125M, marketed 47% median IRR, and is now in harvest mode tracking approximately 4% fund-level trajectory. Burford raised $3.8B in lifetime realizations, reports 26% IRR on concluded matters, and continues to deploy at scale with KPMG-audited financials. The institutional infrastructure — 45+ in-house lawyers, $7.5B portfolio, public company disclosure — makes Burford the benchmark against which all retail litigation finance platforms should be evaluated.

**Does Burford pay dividends?**

Yes — $0.125 per share annually (two semi-annual payments of $0.0625), consistently paid in FY2022, FY2023, FY2024, and FY2025. Total annual dividends approximately $27M. Dividends were suspended during COVID 2020 and restored in 2021. Final dividends require shareholder approval under Guernsey law. Treat BUR as a total-return equity position, not an income vehicle.

**Who should invest in Burford Capital?**

Sophisticated long-term equity investors (5–7 year horizon) seeking alternative asset exposure through liquid public equity who understand fair value accounting mechanics. NOT suitable for: income seekers expecting predictable distributions, short-term traders, investors requiring case-level transparency, risk-averse investors, or anyone who cannot tolerate binary event risk from the YPF concentration.


## Update history

**September 15, 2026: The 2028 maturity resolved: $300M secured notes at 8.000% fund a conditional call of the $400M 6.250% tranche**

Burford filed a Form 8-K on September 14, 2026 (accession 0001714174-26-000099) disclosing that subsidiary Burford Capital Global Finance LLC launched a private offering of $300,000,000 of senior secured notes due 2029, and in the same action delivered a conditional notice to redeem all $400,000,000 of its outstanding 6.250% senior notes due 2028, with a redemption date of September 24, 2026. The redemption is conditioned on the issuer receiving at least $300,000,000 of proceeds from new debt incurrences on or before that date, so it is not unconditional as of the filing. The company's announcement of the same day states the new notes priced at an 8.000% coupon and are secured on a senior lien basis over substantially all of the issuing subsidiary's assets and the capital stock of certain other subsidiaries. This is the direct follow-through on the item recorded in this review's August 10 entry, where management's Exhibit 99.2 named an 'explicit focus on the $400M 2028 maturity, the lowest-coupon debt outstanding.' The resolution is now visible: the cheapest tranche in the stack is being retired and replaced at 175 basis points more, against a lien. The 8-K also states an intention to pursue further de-leveraging, potentially including opportunistic open-market purchases of outstanding debt.

**August 10, 2026: Q2 2026 10-Q verified: YPF marked below cost at $101.1M, book value down 67%, interim dividend suspended — while quarterly cash receipts tripled**

Burford filed its Q2 2026 Form 10-Q (August 6, 2026, accession 0001714174-26-000097) and a concurrent earnings 8-K (accession 0001714174-26-000096, Exhibits 99.1 press release and 99.2 presentation). AltStreet verified both against the documents and ingested the quarter into performance history, which now spans FY2022-FY2025 annual plus Q1 and Q2 2026 quarterly. The half-year reckoning is complete: H1 net loss attributable to shareholders of $1,629.9M ($(7.44) per diluted share) on a $2,397.3M capital provision loss — but Q2 standalone was modestly profitable ($2.2M attributable, $0.01 per diluted share), meaning the damage was a Q1 event. The YPF-related assets (Petersen and Eton Park combined) are now carried at $101.1M against a $125.6M cost basis — below cost — with $8.0M of additional 2026 deployments, and the 10-Q states plaintiffs are 'likely to pursue relief through international arbitration proceedings.' The collateral picture: book value per share $3.73 (from $11.18 at year-end), tangible book $3.12 (from $10.57), debt to tangible book 3.5x (from 0.9x), no interim dividend this year, and roughly $10M of annualized compensation cuts. Offsetting signals: Q2 cash receipts of $157M were the highest since Q1 2025 and more than 3x the prior-year quarter, Item 4 delivers a clean disclosure-controls effectiveness conclusion, and third-party co-investors in the YPF claims absorbed $773.0M of the H1 markdown.

**July 30, 2026: The YPF reversal quantified — a $1.63B quarterly loss with expenses running as a credit — and a $293M Burford fund surfaces in the Form D record**

Two additions from one research pass. First, quarterly performance history now covers Q1 2026 (10-Q filed May 8, 2026, unaudited) — the period containing the March 27, 2026 Second Circuit reversal of the YPF judgment: capital provision income of negative $2,498.8M drove total revenues to negative $1,720.4M and a net loss of $1,632.1M ($7.46 per share); total assets fell from $6,641.2M to $4,269.6M and tangible book value per share to $3.17; and operating expenses ran as a $150.1M credit on reversed YPF-linked incentive-compensation accruals. Second, a full re-enumeration of Burford's SEC Form D family surfaced a vehicle absent from this review's original EDGAR inventory: Burford Advantage Master Fund LP (CIK 1903664), reporting $293,000,000 sold to six investors under Rule 506(b) per its April 8, 2022 Form D/A — a joint three-issuer filing with Delaware and Cayman feeders, relying on Investment Company Act Section 3(c)(7) (qualified purchasers), with an implied average check of roughly $48.8M, the largest in Burford's documented Reg D record. Documented Reg D institutional capital across Burford's closed vehicles rises from $303M to $596M. Monitoring coverage expanded in the same pass: the full twelve-CIK Burford family — both closed funds, all six pre-open Opportunity/Alternative Income entities, both Advantage feeders, the deferred-compensation filer, and the public parent — is now under continuous EDGAR surveillance, meaning future Form D amendments and Exchange Act filings (including 8-K disclosures on YPF enforcement developments) surface as signals automatically rather than by periodic manual sweep.


## Evidence appendix

Platform website captured August 10, 2026.

Primary 10-K filings for FY2024 (filed March 3 2025, accession 0001714174-25-000055) and FY2025 (filed February 26 2026). FY2022 and FY2023 data from comparative periods in the FY2024 10-K. EDGAR Form D filings for 12 Burford-related entities (CIKs 0001714174, 0001930272, 0001714257, 0001760018, 0001760019, 0001760024, 0001760025, 0001760326, 0001760463, 0001903664, 0001903662, 0001922400). Quarterly performance from 10-Q filings (Q1 2026: accession 0001714174-26-000068; Q2 2026: accession 0001714174-26-000097, verified against the filed document with full-text extraction and a zero-residual balance-sheet identity check) plus the August 6, 2026 earnings 8-K (accession 0001714174-26-000096, Exhibits 99.1 and 99.2). Financial data extracted and stored in platform_performance_history via ingestPublicFilings.ts.

**Highlights**

- AltStreet extracted FY2022–FY2025 annual plus Q1 2026 quarterly performance history from primary 10-K and 10-Q filings using ingestPublicFilings.ts — revenue, net income, realizations, total assets, cash, and equity verified from primary source documents.
- Auditor change confirmed from 10-K Item 9: EY dismissed July 1, 2024 effective immediately after Q2 2024 financials; KPMG appointed same day. Both consents in FY2024 10-K.
- Material weakness confirmed from 10-K Item 9A: unremediated ICFR weakness over fair value measurement of capital provision assets as of December 31, 2024. First disclosed FY2023 Form 20-F.
- YPF concentration trajectory verified: 42% (FY2024) → 46% (FY2025) from Notes to Financial Statements capital provision asset breakdowns.
- EDGAR Form D for Burford Capital LLC (CIK 0001714257) confirmed as nonqualified deferred compensation plan — not an investor offering. Six pre-open fund entities confirmed at $0 Reg D capital.

**Primary source pages**

- SEC EDGAR CIK 0001714174 — Burford Capital Ltd (10-K, 10-Q filer)
- 2024 Form 10-K: Consolidated Statements of Operations (FY2022, FY2023, FY2024 comparative)
- 2024 Form 10-K: Consolidated Statements of Financial Condition (FY2023, FY2024)
- 2024 Form 10-K: Note 5 (Capital Provision Assets movements)
- 2024 Form 10-K: Item 9A (Material Weakness — ICFR unremediated)
- 2024 Form 10-K: Item 9 (Auditor change EY → KPMG, July 1 2024)
- 2024 Form 10-K: Note 12 (Debt — $1.763B outstanding)
- 2025 Form 10-K (filed February 26 2026) — FY2025 primary period data
- Q1 2026 Form 10-Q (filed May 8 2026, accession 0001714174-26-000068) — unaudited quarterly impact of the YPF reversal
- SEC EDGAR CIK 0001930272 — Burford Alternative Income Fund II LP Form D ($303M, 7 investors, May 2022)
- SEC EDGAR CIK 0001903664 — Burford Advantage Master Fund LP Form D/A ($293M, 6 investors, April 2022; joint filing with feeder CIKs 0001903662, 0001922400)
- SEC EDGAR CIK 0001714257 — Burford Capital LLC Form D (deferred compensation plan — not investor offering)
- burfordcapital.com — corporate overview, case descriptions, investor materials


## Related

- Full review (HTML): https://altstreet.investments/platforms/reviews/burford-capital
- Every platform review: https://altstreet.investments/platforms/reviews
- Methodology and scoring: https://altstreet.investments/platforms
- Category hub: https://altstreet.investments/categories/litigation-finance

---

Source page: https://altstreet.investments/platforms/reviews/burford-capital
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.